These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30584163)

  • 1. The Future of Brain Imaging in Parkinson's Disease.
    Helmich RC; Vaillancourt DE; Brooks DJ
    J Parkinsons Dis; 2018; 8(s1):S47-S51. PubMed ID: 30584163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Molecular Imaging in Parkinson's Disease.
    Liu ZY; Liu FT; Zuo CT; Koprich JB; Wang J
    Neurosci Bull; 2018 Apr; 34(2):330-340. PubMed ID: 29282614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neuroimaging in Parkinson's disease.
    Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
    J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism.
    Brooks DJ
    Neurotherapeutics; 2021 Apr; 18(2):753-771. PubMed ID: 33432494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging in Parkinson's disease: from pathology to diagnosis.
    Stoessl AJ
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging neurodegeneration in Parkinson's disease.
    Pavese N; Brooks DJ
    Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging in Parkinson's Disease.
    Politis M; Pagano G; Niccolini F
    Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease.
    Abbasi N; Mohajer B; Abbasi S; Hasanabadi P; Abdolalizadeh A; Rajimehr R
    Mov Disord; 2018 Mar; 33(3):431-439. PubMed ID: 29436735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging in Parkinson's disease.
    Brooks DJ
    NeuroRx; 2004 Apr; 1(2):243-54. PubMed ID: 15717025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Magnetic Resonance Imaging and Artificial Intelligence in Studies of Diagnosis of Parkinson's Disease.
    Xu J; Zhang M
    ACS Chem Neurosci; 2019 Jun; 10(6):2658-2667. PubMed ID: 31083923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging advances in Parkinson's disease.
    Rispoli V; Schreglmann SR; Bhatia KP
    Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions.
    Lauretani F; Longobucco Y; Ravazzoni G; Gallini E; Salvi M; Maggio M
    Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33670940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-synuclein imaging: a critical need for Parkinson's disease research.
    Eberling JL; Dave KD; Frasier MA
    J Parkinsons Dis; 2013; 3(4):565-7. PubMed ID: 24192754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: a review.
    Al-Radaideh AM; Rababah EM
    Clin Imaging; 2016; 40(5):987-96. PubMed ID: 27288741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.
    Calabria FF; Calabria E; Gangemi V; Cascini GL
    Hell J Nucl Med; 2016; 19(1):33-41. PubMed ID: 26929938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of biomarkers and imaging in Parkinson's disease.
    Algarni MA; Stoessl AJ
    Expert Rev Neurother; 2016; 16(2):187-203. PubMed ID: 26829357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in neuroimaging: positron emission tomography.
    Stoessl AJ
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S180-3. PubMed ID: 24262176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain PET imaging of phosphodiesterase 10A in progressive supranuclear palsy and Parkinson's disease.
    Koole M; Van Laere K; Ahmad R; Ceccarini J; Bormans G; Vandenberghe W
    Mov Disord; 2017 Jun; 32(6):943-945. PubMed ID: 28394032
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative positron emission tomography in brain research.
    Heurling K; Leuzy A; Jonasson M; Frick A; Zimmer ER; Nordberg A; Lubberink M
    Brain Res; 2017 Sep; 1670():220-234. PubMed ID: 28652218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.